IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,896,894 | +6.1% | 245,551 | +26.1% | 0.00% | +50.0% |
| Q2 2023 | $3,673,649 | -13.0% | 194,682 | -82.3% | 0.00% | -33.3% |
| Q1 2023 | $4,222,664 | +41.2% | 1,099,652 | +82.4% | 0.00% | +50.0% |
| Q4 2022 | $2,990,513 | -30.8% | 602,926 | -33.3% | 0.00% | -33.3% |
| Q3 2022 | $4,323,000 | +19.6% | 904,498 | +12.6% | 0.00% | 0.0% |
| Q2 2022 | $3,614,000 | +312.6% | 803,285 | +336.4% | 0.00% | +200.0% |
| Q1 2022 | $876,000 | -70.1% | 184,082 | -53.3% | 0.00% | -50.0% |
| Q4 2021 | $2,925,000 | +14.2% | 394,015 | -12.8% | 0.00% | 0.0% |
| Q3 2021 | $2,562,000 | -48.9% | 451,926 | -40.6% | 0.00% | -33.3% |
| Q2 2021 | $5,012,000 | +1.1% | 760,569 | +24.3% | 0.00% | 0.0% |
| Q1 2021 | $4,957,000 | +316.6% | 611,917 | +231.7% | 0.00% | +200.0% |
| Q4 2020 | $1,190,000 | +98.3% | 184,489 | +10.8% | 0.00% | – |
| Q3 2020 | $600,000 | -58.4% | 166,574 | -46.9% | 0.00% | -100.0% |
| Q2 2020 | $1,441,000 | +50.6% | 313,433 | +11.7% | 0.00% | 0.0% |
| Q1 2020 | $957,000 | -17.2% | 280,502 | +23.9% | 0.00% | 0.0% |
| Q4 2019 | $1,156,000 | +80.3% | 226,382 | -14.8% | 0.00% | – |
| Q3 2019 | $641,000 | -8.7% | 265,818 | -17.8% | 0.00% | -100.0% |
| Q2 2019 | $702,000 | +53.3% | 323,575 | +91.7% | 0.00% | – |
| Q1 2019 | $458,000 | -82.6% | 168,801 | -69.1% | 0.00% | -100.0% |
| Q4 2018 | $2,627,000 | +124.7% | 547,009 | +343.4% | 0.00% | +200.0% |
| Q3 2018 | $1,169,000 | +28.5% | 123,370 | +32.1% | 0.00% | 0.0% |
| Q2 2018 | $910,000 | -72.1% | 93,423 | -69.9% | 0.00% | -66.7% |
| Q1 2018 | $3,263,000 | +13.0% | 310,072 | -31.2% | 0.00% | +50.0% |
| Q4 2017 | $2,887,000 | +55.0% | 450,435 | +85.0% | 0.00% | 0.0% |
| Q3 2017 | $1,863,000 | +7.4% | 243,428 | -0.2% | 0.00% | 0.0% |
| Q2 2017 | $1,734,000 | +333.5% | 243,824 | +135.8% | 0.00% | – |
| Q1 2017 | $400,000 | -3.8% | 103,391 | -49.2% | 0.00% | – |
| Q4 2016 | $416,000 | -3.9% | 203,693 | +26.1% | 0.00% | – |
| Q3 2016 | $433,000 | -14.8% | 161,564 | -2.1% | 0.00% | -100.0% |
| Q2 2016 | $508,000 | -64.1% | 164,995 | -0.7% | 0.00% | -50.0% |
| Q1 2016 | $1,415,000 | -5.2% | 166,209 | +51.3% | 0.00% | +100.0% |
| Q4 2015 | $1,492,000 | -3.3% | 109,885 | -31.6% | 0.00% | 0.0% |
| Q3 2015 | $1,543,000 | -23.1% | 160,717 | +15.2% | 0.00% | -50.0% |
| Q2 2015 | $2,007,000 | +47.9% | 139,564 | -7.9% | 0.00% | +100.0% |
| Q1 2015 | $1,357,000 | +123.2% | 151,538 | +52.1% | 0.00% | 0.0% |
| Q4 2014 | $608,000 | -12.5% | 99,634 | +52.0% | 0.00% | 0.0% |
| Q3 2014 | $695,000 | +20.9% | 65,568 | +35.0% | 0.00% | 0.0% |
| Q2 2014 | $575,000 | -26.8% | 48,584 | -7.6% | 0.00% | 0.0% |
| Q1 2014 | $785,000 | -22.0% | 52,590 | -23.4% | 0.00% | 0.0% |
| Q4 2013 | $1,007,000 | +26.7% | 68,642 | +47.1% | 0.00% | 0.0% |
| Q3 2013 | $795,000 | +37.1% | 46,668 | +33.4% | 0.00% | 0.0% |
| Q2 2013 | $580,000 | – | 34,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |